The global thermal ablation devices market size is expected to expand at a CAGR of 6.7% during the forecast period, 2021-2028. The growth of the market is attributed to rising demand for minimally invasive procedures.
Thermal ablation refers to the destruction of tissue by extreme hyperthermia (elevated tissue temperatures) or hypothermia (depressed tissue temperatures). The thermal ablation devices such as radiofrequency (RF) ablation has become a common preference for remodeling or rebuilding of the tissues without vaporizing the major structures. Currently, the devices that come under a range of the thermal ablation devices are RF, laser, microwave and high-intensity focused ultrasound (HIFU) technologies, which are used in the treatment of benign prostatic hyperplasia (BPH), cancer/tumor ablation.
Market Drivers, Restraints, Trends, and Opportunities
- Rising prevalence of atrial fibrillation and cancer are encouraging the adoption of thermal ablation devices, driving the growth of the market.
- The emergence of next-generation thermal ablation products and technologies such as radiofrequency ablation, smart catheters, and microwave ablation is anticipated to fuel the growth of the market.
- Growing prevalence of diseases such as cancer and BPH is driving the market growth.
- Favorable reimbursement scenario, safety associated with thermal ablation procedures, and improving economic condition are speculated to propel the growth of the thermal ablation devices market.
- High cost of thermal ablation devices and development of advanced alternative therapeutics can hinder the market growth.
- Increasing technological advancements in thermal ablation systems is anticipated to propel the market growth.
Scope of the Report
The report on the thermal ablation devices market includes an assessment of the market, trends, segments and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Thermal Ablation Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2020
|
Historic Data
|
2018–2019
|
Forecast Period
|
2021–2028
|
Segmentation
|
Type (Interstitial Probes, Grounded Probes, Needle Applications, Radiofrequency Ablation, Hydrothermal Ablation, Microwave Ablation) and Applications (Hospitals, Ambulatory Surgical Centers (ASCs), and Clinics)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Medtronic, Inc., Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, and AtriCure, Inc., CONMED Corporation, AngioDynamics, Inc., Smith & Nephew plc , and Olympus Corporation.
|
Global Thermal Ablation Devices Market Insights
Radiofrequency ablation segment to account a large market share
Based on types, the market is categorized as interstitial probes, grounded probes, needle applications, radiofrequency ablation, hydrothermal ablation, microwave ablation. The radiofrequency ablation segment is estimated to account for a large market share during the forecast period. Low cost of radiofrequency ablation procedures as compared to other ablation techniques coupled with its high safety, efficacy, and short procedural duration for the treatment of cancer, atrial fibrillation, and pain management is driving the market segment.
Microwave ablation treatment has achieved high success in cancer treatment and offer advantages of RF ablation, as it can produce larger ablation zones. This factor is anticipated to drive the segment growth.
Hospitals segment to exhibit a high CAGR
Based on applications, the market is segregated into hospitals, ambulatory surgical centers (ASCs), and clinics. Increasing adoption of thermal ablation devices in hospitals is driving the growth of the market segment. The hospitals segment is projected to expand at a high CAGR of 6.7% during the forecast period.
Europe is projected to account a considerable market share
On the basis of regions, the market is segregated into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Europe is expected to dominate the global thermal ablation devices market owing to growing healthcare expenditure and rising investment on improvement of healthcare facilities in the region. However, the market in Asia Pacific is expected to expand at a high CAGR owing to large patient pool and growing investment in the healthcare industry.
Segments
Segments Covered in the Report
The global market for thermal ablation devices has been segmented on the basis of
Types
- Interstitial Probes
- Grounded Probes
- Needle Applications
- Radiofrequency Ablation
- Hydrothermal Ablation
- Microwave Ablation
Application
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Clinics
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East
- Africa
Key players
- Medtronic, Inc.
- Biosense Webster Inc.
- St. Jude Medical, Inc.
- Boston Scientific Corporation
- AtriCure, Inc.
- CONMED Corporation
- AngioDynamics, Inc.
- Smith & Nephew plc
- Olympus Corporation
Competitive Landscape
Some of the leading manufacturers in the global market for thermal ablation devices are Medtronic, Inc., Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, and AtriCure, Inc., CONMED Corporation, AngioDynamics, Inc., Smith & Nephew plc, and Olympus Corporation.
Companies are focusing on partnering with hospitals and clinics to expand their market share.